These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever. Bodur H, Erbay A, Akıncı E, Öngürü P, Bayazıt N, Eren SS, Kubar A. Int J Infect Dis; 2011 Jan; 15(1):e44-7. PubMed ID: 21106428 [Abstract] [Full Text] [Related]
12. An Unexpected Fatal CCHF Case and Management of Exposed Health Care Workers. Guven G, Talan L, Altintas ND, Memikoglu KO, Yoruk F, Azap A. Int J Infect Dis; 2017 Feb; 55():118-121. PubMed ID: 28069471 [Abstract] [Full Text] [Related]
13. Investigating the effect of ribavirin treatment on genetic mutations in Crimean-Congo haemorrhagic fever virus (CCHFV) through next-generation sequencing. D'Addiego J, Elaldi N, Wand N, Osman K, Bagci BK, Kennedy E, Pektas AN, Hart E, Slack G, Hewson R. J Med Virol; 2023 Feb; 95(2):e28548. PubMed ID: 36734067 [Abstract] [Full Text] [Related]
15. Ribavirin is not effective against Crimean-Congo hemorrhagic fever: observations from the Turkish experience. Ceylan B, Calıca A, Ak O, Akkoyunlu Y, Turhan V. Int J Infect Dis; 2013 Oct; 17(10):e799-801. PubMed ID: 23773242 [Abstract] [Full Text] [Related]